Aquilus Pharmaceuticals

LEADING THE WAY IN NEURODEGENERATIVE DISEASE TREATMENT

Aquilus Pharmaceuticals (Aquilus) is a biotech company focused on the treatment of neurodegenerative diseases, in particular Amyotrophic Lateral Sclerosis (ALS). Our dedicated team is committed to developing innovative therapies that aim to improve the lives of patients affected by these debilitating conditions. Through extensive research and collaboration, we are striving to make a meaningful difference in the field of neurology and bring hope to those in need. We are driven by a passion for scientific advancement and a deep-rooted desire to positively impact the lives of individuals and families impacted by neurodegenerative diseases.